Medical degree at Santa Casa School of Medicine, specialized in Internal Medicine at Santa Casa of São Paulo, Infectious Diseases at Hospital das Clínicas Medicine School, USP. PhD in Pathology at Hospital das Clínicas Medicine School, USP. MBA in Business Management from FGV-SP. Since March 2002 in Teaching Hospital, Irmandade da Santa Casa de São Paulo, as medical assistant of Internal Medicine Emergency. Experience as healthcare administrator since 2004.From 2004 to 2012 promoted to Director of Santa Casa de São Paulo Infection Control Service, leading cross-departmental projects and reporting to the CEO. In 2013, promoted to Director of Internal Medicine. In 2014, promoted to CEO of the institution, following the financial distress of the institution on the verge of bankruptcy. The role represented a key management experience, as it encompassed full accountability over management of the largest philanthropic hospital in Latin America.In September 2015, I felt it was my mission to inspire others to learning innovation in my hospital and academy. To pursue my ambition, I founded startups focus on patient engagement and social impact. Since 2018, COO of EZVIDA, a health-tech that provides epidemiologic intelligence and predictive modeling, offering broad possibilities for analysis and fast insight generation to enable timely and assertive decision-making for better companies’ results. EZVIDA contributes to increase satisfaction and productivity of workers in companies by reducing absences caused by factors associated with collaborator’s health. In 2019, founder of Ionmedicine, a laboratory that investigates metabolomics as a diagnostic option of relevant clinical disorders through quantification and identification of final products of the metabolism and biological system to obtain predictive, precise and personalized results. Since 2019 he is vice chancellor of the Santa Casa School of Medicine.
Invited by: Ana Kemp
if the data has not been changed, no new rows will appear.
Day | Followers | Gain | % Gain |
---|---|---|---|
November 19, 2023 | 127 | +3 | +2.5% |
June 28, 2022 | 124 | +1 | +0.9% |
October 23, 2021 | 123 | +1 | +0.9% |
September 17, 2021 | 122 | +3 | +2.6% |